http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8207294-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d6b28a3576a7db24826dea7f1135b13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 1982-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4772a04d3fd02977660194710ce53782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e598140b29bc25eba43decf99583ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a55d2ca8d7382111316bb20ea0ba9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b71f1c73bf7244e7a6f55c49b8dcd45f
publicationDate 1982-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8207294-D0
titleOfInvention 1,4-THIAZANCARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE AND COMPOSITIONS OF THESE DERIVATIVES
abstract Derivatives of 1,4-thiazane-3-carboxylic acid represented by the formula I, wherein R1 and R2 are hydrogen, an alkyl radical or a phenyl nucleus substituted or not or form a cycloalkyl radical; R3 is a hydroxyl group, OR9 group, wherein R9 may have different significations; R4 is hydrogen, alkyl or CONH2, R3 and R4 forming a hydantoin cycle, R5 and R6 representing hydrogen, alkyl, phenyl substituted or not; R7 is hydrogen, alkyl, particularly dimethyl, phenyl substituted or not, and the salts of those compounds. <IMAGE> as well as the pharmaceutical compositions containing them and the intermediaries for their preparation, having the formulas II, III, IV: <IMAGE>.
priorityDate 1981-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 39.